Tenase complex

The Tenase complex assembly describes the formation of multiprotein enzyme complexes essential for blood coagulation. The intrinsic tenase complex is composed of activated factor VIII (factor VIIIa) and activated factor IX (factor IXa) bound to phospholipid surfaces, catalyzing activation of factor X to factor Xa—a step greatly accelerating thrombin generation and clot formation[2]. The extrinsic tenase complex consists of tissue factor and activated factor VIIa, serving as the primary initiator of the coagulation cascade, especially after vascular injury[1]. These complexes are tightly regulated to maintain hemostasis and are primary targets for therapeutic intervention in bleeding and thrombotic disorders[1][2].

Other names

Intrinsic tenase complex (factor VIIIa–factor IXa)Extrinsic tenase complex (tissue factor–factor VIIa)Xase complex

Drugs targeting the Tenase complex work through various mechanisms, including inhibition of its assembly (e.g., antagonists against tissue factor, factor VIIIa, or IXa), cofactor supplementation (e.g., replacement therapies for factor VIII/IX deficiency), or inhibition of downstream protease activity (e.g., factor Xa inhibition).